鹅去氧胆酸钠 ,CHENODESOXYCHOLIC ACID SODIUM SALT ,≥97%

产品编号:SIGMA-C8261| CAS NO:2646-38-0| 分子式:C24H40NaO4| 分子量:415.5618

鹅去氧胆酸钠是一种疏水性初级胆汁酸,可激活参与胆固醇代谢的核受体(FXR)。

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
SIGMA-C8261
605.00 杭州 北京(现货)
SIGMA-C8261
1035.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

产品名称 鹅去氧胆酸钠
英文名称CHENODESOXYCHOLIC ACID SODIUM SALT
CAS编号2646-38-0
产品描述鹅去氧胆酸钠是一种疏水性初级胆汁酸,可激活参与胆固醇代谢的核受体(FXR)。
产品熔点298 °C(dec.)
产品沸点547.1ºC at 760mmHg
产品闪点298.8ºC
精确质量414.274597
PSA80.59000
LogP3.14320
外观性状固体;White to Almost white powder to crystal
蒸气压2.98E-14mmHg at 25°C
体外研究

鹅去氧胆酸钠(CDCA)和脱氧胆酸(DCA)均抑制11β-HSD2,IC50值分别为22 mM和38 mM,并导致皮质醇依赖性核转位,增加盐皮质激素受体(MR)的转录活性。鹅去氧胆酸钠能够通过激活膜G蛋白偶联受体(TGR5)依赖性途径,诱导细胞周期蛋白D1蛋白和mRNA表达显著增加,从而刺激石川细胞生长。在培养的人肝母细胞瘤细胞系Hep G2中,鹅去氧胆酸钠(CDCA)诱导LDL受体mRNA水平约为4倍,HMG-CoA还原酶和HMG-CoA合成酶的mRNA水平为2倍。鹅去氧胆酸钠诱导的Isc被布美他奈、BaCl2和囊性纤维化跨膜电导调节剂(CFTR)抑制剂CFTRin-172抑制(≥67%)。腺苷酸环化酶抑制剂MDL12330A使鹅去氧胆酸钠刺激的Isc降低43%,鹅去氧胆酸盐增加细胞内cAMP浓度。鹅去氧胆酸钠处理激活C/EBPβ,如其磷酸化、核积累和在HepG2细胞中表达的增加所示。鹅去氧胆酸钠增强来自含有-1.65-kb GSTA2启动子的构建体的萤光素酶基因转录,该构建体含有C/EBP应答元件(pGL-1651)。鹅去氧胆酸钠处理激活AMP活化蛋白激酶(AMPK),导致细胞外信号调节激酶1/2(ERK1/2)激活,使用AMPKα显性阴性突变体和化学抑制剂的实验结果证明了这一点[5]。

细胞实验

通过用相应浓度的胆汁酸孵育转染的HEK-293细胞和CHO细胞1小时并用台盼蓝染色来分析细胞活力。根据细胞增殖试剂盒I,使用四唑盐MTT(3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑溴化物)分析胆汁酸的毒性。在两种测试中,对照和胆汁酸处理的细胞之间没有显著差异。

稳定性

如果遵照规格使用和储存则不会分解。

储存条件

密封于阴凉干燥环境。

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


符号 GHS07 GHS08
GHS07, GHS08
信号词 Warning
危害声明 H302-H312-H332-H351
警示性声明 P280-P281
危害码 (欧洲) Xn: Harmful;
风险声明 (欧洲) 20/21/22-40
安全声明 (欧洲) S22;S36
危险品运输编码 NONH for all modes of transport
RTECS号 FZ2231000

Section1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name: Sodium chenodeoxycholate
CAS-No.: 2646-38-0
Relevant identified uses of the substance or mixture and uses advised against
Identified uses: Laboratory chemicals, Manufacture of substances



Section2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 [EU-GHS/CLP]
Acute toxicity, Inhalation (Category 4)
Acute toxicity, Dermal (Category 4)
Acute toxicity, Oral (Category 4)
Carcinogenicity (Category 2)
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Harmful by inhalation, in contact with skin and if swallowed. Limited evidence of a carcinogenic effect.
Label elements
Labelling according Regulation (EC) No 1272/2008 [CLP]
Pictogram
Signal wordWarning
Hazard statement(s)
H302Harmful if swallowed.
H312Harmful in contact with skin.
H332Harmful if inhaled.
H351Suspected of causing cancer.
Precautionary statement(s)
P280Wear protective gloves/ protective clothing.
P281Use personal protective equipment as required.
Supplemental Hazardnone
Statements
Safety data sheet available on request.
According to European Directive 67/548/EEC as amended.
Hazard symbol(s)
R-phrase(s)
R20/21/22Harmful by inhalation, in contact with skin and if swallowed.
R40Limited evidence of a carcinogenic effect.
S-phrase(s)
S22Do not breathe dust.
S36Wear suitable protective clothing.
Other hazards - none

Section3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
: 5β-Cholanic acid-3α,7α-diol
Synonyms
Chenodesoxycholic acid
Chenodeoxycholic acidsodium salt
Chenodiol
3α,7α-Dihydroxy-5β-cholanic acid
Formula: C24H39NaO4
Molecular Weight: 414,55 g/mol
ComponentConcentration
3α,7α-Dihydroxy-5β-cholan-24-oic acid sodium salt
CAS-No.2646-38-0-

Section4. FIRST AID MEASURES
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Indication of any immediate medical attention and special treatment needed
no data available

Section5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, Sodium oxides
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

Section6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or gas. Ensure
adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust.
Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

Section7. HANDLING AND STORAGE
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.Normal measures for preventive fire
protection.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end uses
no data available

Section8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested
and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face particle
respirator type N100 (US) or type P3 (EN 143) respirator cartridges as a backup to engineering
controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Use
respirators and components tested and approved under appropriate government standards such
as NIOSH (US) or CEN (EU).

Section9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) AppearanceForm: solid
b) Odourno data available
c) Odour Thresholdno data available
d) pHno data available
e) Melting point/freezingno data available
point
f) Initial boiling point and no data available
boiling range
g) Flash pointno data available
h) Evaporation rateno data available
i) Flammability (solid, gas) no data available
j) Upper/lowerno data available
flammability or
explosive limits
k) Vapour pressureno data available
l) Vapour densityno data available
m) Relative densityno data available
n) Water solubilityno data available
o) Partition coefficient: n- no data available
octanol/water
p) Autoignitionno data available
temperature
q) Decompositionno data available
temperature
r) Viscosityno data available
s) Explosive propertiesno data available
t) Oxidizing propertiesno data available
Other safety information
no data available

Section10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available

Section11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Inhalation: no data available
Dermal: no data available
LD50 Intravenous - rat - 100 mg/kg
Remarks: Respiratory disorder
LD50 Intravenous - mouse - 114 mg/kg
Remarks: Lungs, Thorax, or Respiration:Acute pulmonary edema.
LD50 Subcutaneous - mouse - 1.450 mg/kg
Remarks: Gastrointestinal:Ulceration or bleeding from small intestine. Skin and Appendages: Other: Hair.
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
Limited evidence of a carcinogenic effect.
IARC:No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
InhalationHarmful if inhaled. May cause respiratory tract irritation.
IngestionHarmful if swallowed.
SkinHarmful if absorbed through skin. May cause skin irritation.
EyesMay cause eye irritation.
Signs and Symptoms of Exposure
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Additional Information
RTECS: Not available

Section12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

Section13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed
professional waste disposal service to dispose of this material. Dissolve or mix the material with a
combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

Section14. TRANSPORT INFORMATION
UN number
ADR/RID: -IMDG: -IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA:Not dangerous goods
Transport hazard class(es)
ADR/RID: -IMDG: -IATA: -
Packaging group
ADR/RID: -IMDG: -IATA: -
Environmental hazards
ADR/RID: noIMDG Marine pollutant: noIATA: no
Special precautions for user
no data available

Section15. REGULATORY INFORMATION
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment
no data available

Section16. OTHER INFORMATION
Further information
Copyright 2012 Co. LLC. License granted to make unlimited paper copies for internal use
only.
The above information is believed to be correct but does not purport to be all inclusive and shall be
used only as a guide. The information in this document is based on the present state of our knowledge
and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Corporation and its Affiliates shall not be held
liable for any damage resulting from handling or from contact with the above product. See
and/or the reverse side of invoice or packing slip for additional terms and conditions of sale.
上游产品  1

下游产品  2

服务热线

13911702513
18601927057

微信客服